26U vs GALD: Side-by-Side Comparison
Compare 26U (26U) and Galderma Group N (GALD) side by side: market cap EUR 127.86M vs CHF 43.03B. Financials, growth and model signals on Bullrun.
| Metric | 26U | GALD |
|---|---|---|
| Company | 26U | Galderma Group N |
| Country / Exchange | Switzerland · F | Switzerland · SW |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 127.86M | CHF 43.03B |
| P/E ratio | — | 88.2 |
| Dividend yield | — | 0.19% |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 10.80M | CHF 5.24B |
| Revenue growth YoY | +56.6% | +18.0% |
| Net income | EUR -1.42M | CHF 613.00M |
| Gross margin | 26.3% | 68.9% |
| Diluted EPS | -0.28 | — |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.